Dihexa crosses the blood-brain barrier and demonstrates oral bioavailability, properties that are rare among cognitive-enhancing peptides
Liraglutide was finally approved in 2010 for the treatment of patients with type 2 diabetes unable to regulate their blood sugar with other insulin medications (Gilbert, Rosenthal, Jan 2024)
It can also help rule out other causes of an enlarged thyroid, such as thyroid nodules
Additionally, female participants demonstrated a more pronounced HbA1c reduction compared to male participants (3.23% vs 1.35%, respectively
Morzhina et al., 2000) as well as boron deficiency (Bolaos et al., 2001), cadmium exposure (Tsyganova et al., 2019c
Over time, this constant strain can lead to serious, life-threatening conditions, including heart attack and stroke, especially in individuals with undiagnosed heart conditions